Show results for
Refine by
Tumor Cells Services Available In Iran
33 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Antibody-drug conjugates employ the specific monoclonal antibodies (mAbs) to achieve targeted delivery of the conjugated cytotoxic molecules to tumor cells. This delicate design increases the payload efficacy against tumor cells and in the meantime, reduces the cytotoxicity of the otherwise highly toxic payload to normal tissues ...
by:Biointron based inShanghai, CHINA
With the current biotherapeutic market dominated by antibody molecules, bispecific antibodies represent a key component of the next-generation of antibody therapy. Bispecific antibodies can target two different antigens at the same time, such as simultaneously binding tumor cell receptors and recruiting cytotoxic immune cells. BioIntron has ...
by:Protheragen-ING based inNEW YORK (USA)
Anti-tumor APIs are a class of drugs that inhibit or kill tumor cells in the body, which are classified as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormone therapy drugs according to the mode of action. Chemotherapy API works by interfering with the cell division process, thereby inhibiting the growth ...
Manufactured by:Immatics N.V. based inTuebingen, GERMANY
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
γδ T cells are a distinct subgroup of T cells containing T cell receptors (TCRs) γ and TCR δ chains. Compared to αβ T cells, γδ T cells without MHC restriction on tumor antigen recognition have strong cytotoxic effects on tumor cells. γδ T cells ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of ...
by:Trion Research GmbH based inPuchheim, GERMANY
We combine leading scientific expertise in tumor immunology and virus-induced immune disorders with dedicated analytical know-how. Our services comprise Liquid Biopsy diagnostics with the analysis of virus-infected cells and the detection of disseminated tumor cells in blood, urine and other body fluids. Moreover, we offer the ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Tumor-derived cell lines have long been used to discover the biologic processes in oncology, as well as screening platforms for discovering and evaluating the efficacy of anti-tumor therapeutics. ...
Manufactured by:Creative Biogene-Mitochondrial Research based inNY, NEW YORK (USA)
Cancer cells have a different metabolism than normal cells, which allows them to survive longer and grow faster. Resistance to apoptosis is a key feature of cancer cells, and given the importance of mitochondria in apoptosis, it is crucial to study the behavior of mitochondria in tumors. ...
Manufactured by:Elpiscience based inShanghai, CHINA
Elpiscience’s proprietary discovery technologies enable efficient generation of innovative cancer ...
Manufactured by:Neutron Therapeutics, Inc. based inDanvers, MASSACHUSETTS (USA)
A Promising Non-Invasive Therapy for Cancer Patients; Boron Neutron Capture Therapy (BNCT) is a unique type of radiation therapy that enables targeting of cancer at the cellular level. BNCT has been used to treat cancer with a non-invasive two-step process.* First, patients are injected with a tumor-seeking drug containing a non-radioactive isotope (boron-10) with a high neutron capture ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug candidate against the disease and evaluate if the drug acts on the ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
To accurately interpret gene expression in tissues, scientists are in need of a quantitative assay that provides spatial information at the molecular level. The RNAscope™, BaseScope™, and miRNAscope™ ISH technologies enable single molecule detection of RNAs in situ within the tissue context. Our highly trained scientific experts and pathologists offer various quantification ...
Manufactured by:Neovii Pharmaceuticals AG based inRapperswil, SWITZERLAND
Stem cell transplantation is a potentially curative procedure and an established therapeutic option for a number of diseases, primarily malignant diseases of the blood. In recent years, stem cell transplantation has also become an alternative therapeutic option for the treatment of other serious diseases, such as some autoimmune ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
Our colorectal cancer program utilizes engineered phage with various payloads (such as immunostimulatory payloads) that are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. The aim of payload delivery is to convert cold tumors to hot tumors with activated immune responses. ...
by:Chimeric Therapeutics based inCarlton South, AUSTRALIA
Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. The most common and simple type of cell therapy is a blood transfusion. Other commonly known cell therapies include red and white blood cell transfusions and bone marrow ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the ...
Manufactured by:ImCare Biotech, LLC based inDoylestown, PENNSYLVANIA (USA)
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following surgical resection. Because recurrence of cancer often implies the immune system’s inability to clear lingering oncogenic cells, early cancer ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...